Fibroblast growth factor receptors (FGFRs) are important oncology targets due to the dysregulation of this signaling pathway in a wide variety of human cancers. We identified a series of pyrazolylaminoquinazoline derivatives as potent FGFR inhibitors with low nanomolar potency. The representative compound 29 strongly inhibited FGFR1-3 kinase activity and suppressed FGFR signaling transduction in FGFR-addicted
[EN] SMALL MOLECULE COVALENT ACTIVATORS OF UCP1<br/>[FR] ACTIVATEURS COVALENTS À PETITES MOLÉCULES D'UCP1
申请人:DANA FARBER CANCER INST INC
公开号:WO2021257660A1
公开(公告)日:2021-12-23
Disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salts thereof. The compounds of Formula (I) are useful for activating uncoupling protein 1 (UCP1) dependent thermogenesis. Also disclosed herein are methods of treating obesity or metabolic disorders such as diabetes using a compound of Formula (I).